We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ONCR

Price
-
Stock movement up
+- (%)
Company name
Oncorus Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
3.15M
Ent value
60.56M
Price/Sales
-
Price/Book
0.10
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
287.78%
3 year return
-77.09%
5 year return
-
10 year return
-
Last updated: 2024-12-17

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

ONCR does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book0.10
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count26.09M
EPS (TTM)-3.61
FCF per share (TTM)-2.83

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)0.00
Operating income (TTM)-59.27M
Net income (TTM)-94.27M
EPS (TTM)-3.61
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash21.22M
Net receivables0.00
Total current assets46.67M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment59.07M
Total assets109.75M
Accounts payable2.76M
Short/Current long term debt69.25M
Total current liabilities31.11M
Total liabilities78.63M
Shareholder's equity31.12M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-55.70M
Capital expenditures (TTM)18.14M
Free cash flow (TTM)-73.84M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-302.90%
Return on Assets-85.89%
Return on Invested Capital-178.38%
Cash Return on Invested Capital-139.72%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Downside potential

Loading...
Downside potential data
ONCRS&P500
Current price drop from All-time high-99.66%-4.34%
Highest price drop-99.97%-56.47%
Date of highest drop14 Dec 20239 Mar 2009
Avg drop from high-82.81%-11.07%
Avg time to new high43 days12 days
Max time to new high924 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ONCR (Oncorus Inc) company logo
Marketcap
3.15M
Marketcap category
Small-cap
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company develops ONCR-021 for the treatment of non-small cell lung cancer, renal cell carcinoma, melanoma, and anaplastic thyroid cancer; and ONCR-788 for the treatment of small cell lung cancer, neuroendocrine prostate, and other neuroendocrine cancers. Oncorus, Inc. was incorporated in 2015 and is headquartered in Andover, Massachusetts.
Employees
64
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...